Alto Neuroscience, Inc. Share Price (NYSE: ANRO)

Alto Neuroscience, Inc. Stock Performance

as on October 14, 2025 at 1:29 am IST

Day's Low
Day's High
$5.61
Day's Price Range
$5.95
$5.93
5.40%
Downside
0.34%
Upside
52 Week's Low
52 Week's High
$1.6
52-Week Price Range
$15.04
$5.93
73.02%
Downside
153.63%
Upside

Alto Neuroscience, Inc. share price movements today

Previous Close: $5.64
Open: $5.75
Volume: 577.5K
Day's Low - High: $5.61 - $5.95
52 Week Low - High: $1.6 - $15.04

Alto Neuroscience, Inc. Historical Returns

1 Month Return: + 44.99 %
3 Month Return: + 116.92 %
1 Year Return: -58.35 %
3 Year Return: 0 %
5 Year Return: 0 %

Alto Neuroscience, Inc. Stock Fundamentals & Key Indicators

Check Alto Neuroscience, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$152.7M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-69.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

8400.00%

Alto Neuroscience, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alto Neuroscience, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Alto Neuroscience, Inc.	BUY	$152.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.4B	213.96%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.6B	47.7%	28.98	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.8B	-7.13%	14.23	31.37%

Stock Returns calculator for Alto Neuroscience, Inc. Stock including INR - Dollar returns

The Alto Neuroscience, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Alto Neuroscience, Inc. investment value today

Current value as on today

₹49,402

Returns

₹50,598

(-50.6%)

Returns from Alto Neuroscience, Inc. Stock

₹56,204 (-56.2%)

Dollar Returns*

₹5,606 (+5.61%)

Analyst Recommendation on Alto Neuroscience, Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Alto Neuroscience, Inc.. Average target price of $11

Alto Neuroscience, Inc. Share Price Target

Get share price movements and forecasts by analysts on Alto Neuroscience, Inc..

What analysts predicted

46.09%UPSIDE

Target Price

$11

Current Price

$5.93

Analyzed by

11 Analysts

Target

$11.00

Alto Neuroscience, Inc. target price $11, a slight upside of 46.09% compared to current price of $5.93. According to 11 analysts rating.

Alto Neuroscience, Inc. Stock’s Investor Sentiment and Interest

Search interest for Alto Neuroscience, Inc. Stock has increased by 800% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 14, 2025 to October 14, 2025

Change:800% versus previous 30 day period

Alto Neuroscience, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-7	-9	-9	-11	-14	-18	-18	-16	-15	-18
EBITDA	-6	-8	-8	-10	-12	-15	-16	-14	-14	-18
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-8	-9	-11	-13	-16	-16	-15	-15	-17
Income Tax Expense	-	-	0	0	-	0	-	-	-	-
Net Income	-7	-8	-9	-11	-13	-16	-16	-15	-15	-17
Net Profit Margin	0.00%	0.00%	0.00%	-3015.32%	0.00%	0.00%	0.00%	-3858.12%	0.00%	0.00%

Alto Neuroscience, Inc. Annual Profit & Loss

All numbers in Millions USD

	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Revenue	0	-	-	-
Gross Profit	0	0	0	0
Operating Income	-12	-29	-37	-68
EBITDA	-9	-27	-34	-68
Interest Expense	-	-	1	1
Depreciation	0	0	0	0
Income Before Tax	-9	-27	-36	-61
Income Tax Expense	-	-	-	-61
Net Income	-9	-27	-36	-61
Net Profit Margin	-4374.76%	0.00%	0.00%	0.00%

Alto Neuroscience, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-9	-11	-13	-16	-16	-15	-15	-17
Operating Cash Flow	-6	-7	-11	-10	-11	-11	-13	-16	-13
Investing Cash Flow	0	0	0	0	0	-1	0	0	-
Financing Cash Flow	0	0	43	134	0	1	0	9	0
Change in Cash	-6	-7	31	123	-12	-11	-13	-7	-13

Alto Neuroscience, Inc. Annual Cash Flow

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024
Net Income	-27	-36	-61
Operating Cash Flow	-20	-33	-47
Investing Cash Flow	0	0	-2
Financing Cash Flow	43	68	135
Change in Cash	22	34	86

Insights on Alto Neuroscience, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.0% return, outperforming this stock by 120.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ANRO stock has moved down by -13.8%

About Alto Neuroscience, Inc.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on redefining psychiatry by leveraging neurobiology to develop personalized and effective treatment options. The Company's Precision Psychiatry Platform measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to identify which patients are likely to respond to its product candidates. Its clinical-stage pipeline includes drug candidates in bipolar depression, major depressive disorder, treatment resistant depression (TRD), and schizophrenia, and other mental health conditions. Its product candidates include ALTO-100, ALTO-300, ALTO-207, ALTO-203, ALTO-101, ALTO-202, and ALTO-208. ALTO-100 is a first-in-class, oral small molecule believed to work through enhancing neural plasticity in the hippocampus, a brain region important for both cognition and mood. ALTO-203 is an oral small molecule histamine H3 receptor inverse agonist.

Organisation	Alto Neuroscience, Inc.
Headquarters	650 Castro Street, Mountain View, CA, United States, 94041
CEO	Dr. Amit Etkin M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Alto Neuroscience, Inc.

Name	Title
Dr. Amit Etkin M.D., Ph.D.	Founder, Chairman of the Board, CEO & President
Mr. Nicholas C. Smith	CFO & Chief Business Officer
Mr. Michael C. Hanley M.B.A.	Chief Operating Officer
Mr. Dan Segal B.Sc. (Hons), BCom, CA, MSc	Co-Founder & Strategic Advisor
Ms. Erin R. McQuade J.D.	General Counsel, Chief Administrative Officer & Corporate Secretary
Mr. Adam Savitz M.D., Ph.D.	Chief Medical Officer
Ms. Jessica Powell	Chief Development Officer

FAQs

What is Alto Neuroscience, Inc. share price today?

Alto Neuroscience, Inc. share price today is $5.93 as on October 14, 2025 at 1:29 am IST at the close of the market. Alto Neuroscience, Inc. share today touched a day high of $5.95 and a low of $5.61.

What is the 52 week high and 52 week low for Alto Neuroscience, Inc. share?

Alto Neuroscience, Inc. share touched a 52 week high of $15.04 on October 17, 2024 and a 52 week low of $1.6 on April 4, 2025. Alto Neuroscience, Inc. stock price today i.e. October 14, 2025 at 1:29 am IST is closed at $5.93,which is 60.57% down from its 52 week high and 270.63% up from its 52 week low.

What is Alto Neuroscience, Inc.'s market capitalisation today?

Alto Neuroscience, Inc. market capitalisation is $0.00T as on October 14, 2025 at 1:29 am IST.

How to invest in Alto Neuroscience, Inc. Stock (ANRO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alto Neuroscience, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alto Neuroscience, Inc. Shares that will get you 0.2530 shares as per Alto Neuroscience, Inc. share price of $5.93 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Alto Neuroscience, Inc. Stock (ANRO) from India?

Indian investors can start investing in Alto Neuroscience, Inc. (ANRO) shares with as little as ₹88.635 or $1 (as of October 14, 2025 at 3:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Alto Neuroscience, Inc. stock (as per the Rupee-Dollar exchange rate as on October 14, 2025 at 3:39 am IST). Based on Alto Neuroscience, Inc. share’s latest price of $5.93 as on October 14, 2025 at 1:29 am IST, you will get 1.6863 shares of Alto Neuroscience, Inc.. Learn more about fractional shares .